Clinical Trials Directory

Trials / Completed

CompletedNCT02432599

Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Centre Francois Baclesse · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The rationale for the proposed pilot study is to investigate the ability of PET-CT with F18-choline to detect and locate the parathyroid adenoma in patients with primary hyperparathyroidism and negative or non-contributory MIBI (Tc-99m sestamibi) and cervical ultrasound, in order to avoid unnecessary bilateral cervical exploration.

Conditions

Interventions

TypeNameDescription
RADIATIONF18-choline PET examinationF18-choline PET examination will be performed before surgery

Timeline

Start date
2015-03-01
Primary completion
2017-02-01
Completion
2017-02-01
First posted
2015-05-04
Last updated
2018-01-04

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02432599. Inclusion in this directory is not an endorsement.